Depletion of B cells by anti-CD20 prevented diabetes in NOD mice (37, 38) and delayed the loss of insulin in T1D in humans, which was more effective in younger patients (5), underscoring the contribution of B cells to T1D pathology. Here, INS is linked to type 1 diabetes mellitus.